- Digital PCR
- NGS Enrichment
- News & Events
The ThunderBolts™ Myeloid Panel is a next-generation sequencing (NGS) assay for studying important mutations in known genes implicated in the causation, prognosis and recurrence of myeloid disorders. Developed in collaboration with a consortium of hematology oncology experts from comprehensive cancer centers in the U.S. and Europe, the panel runs on the ThunderBolts™ System and features NGS breakthroughs in sequence coverage and uniformity, allelic sensitivity, sample input requirements, and workflow.
(Click image to enlarge)
The ThunderBolts Myeloid Panel uses 548 amplicons1 to interrogate mutations/hotspots in 49 myeloid disorder genes
Get in touch with our team to learn how to purchase the ThunderBolts Myeloid Panel.
RECEIVE EMAIL UPDATES:
LIVE TWITTER FEED